"This work represents a promising new line of vaccine development but more research would be needed to see if this could be replicated safely in humans," said Doctorr Clive Holmes of the Alzheimer's Research Trust. The vaccine is given by an injection and works by reducing the amount of certain amyloid proteins, which scientists believe are the cause of the illness. The study says that the amount of amyloid proteins in different areas of the brain was reduced, in some cases, up to 50\%. In the lowest amounts, the protien was reduced 15.5\%. In direct areas of the brain, such as the hippocampus and cerebral cortex, the reduction of the protein was 40-50\%. Amyloid proteins, when over produced, are believed to cause the symptoms of the illness by forming masses in the brain, which spread. The vaccine involves injecting the mice with the protein and then the DNA vaccine. The vaccine codes itself to the protein, stopping the spread of the masses by not allowing the protein to reproduce.
"This work represents a promising new line of vaccine development but more research would be needed to see if this could be replicated safely in humans," said Doctor Clive Holmes of the Alzheimer's Research Trust. The vaccine is given by an injection and works by reducing the amount of certain amyloid proteins, which scientists believe are the cause of the illness. The study says that the amount of amyloid proteins in different areas of the brain was reduced, in some cases, up to 50\%. In the lowest amounts, the protein was reduced 15.5\%. In direct areas of the brain, such as the hippocampus and cerebral cortex, the reduction of the protein was 40-50\%. Amyloid proteins, when over produced, are believed to cause the symptoms of the illness by forming masses in the brain, which spread. The vaccine involves injecting the mice with the protein and then the DNA vaccine. The vaccine codes itself to the protein, stopping the spread of the masses by not allowing the protein to reproduce.
R
Doctorr
Doctor
R
protien
protein